Related references
Note: Only part of the references are listed.Discovery and optimization of withangulatin A derivatives as novel glutaminase 1 inhibitors for the treatment of triple-negative breast cancer
Wu-Xi Zhou et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2021)
1,2,4-Oxadiazole topsentin analogs as staphylococcal biofilm inhibitors targeting the bacterial transpeptidase sortase A
Barbara Parrino et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2021)
Thiazole Analogues of the Marine Alkaloid Nortopsentin as Inhibitors of Bacterial Biofilm Formation
Anna Carbone et al.
MOLECULES (2021)
UniProt: the universal protein knowledgebase in 2021
Alex Bateman et al.
NUCLEIC ACIDS RESEARCH (2021)
Nrf2 Activation Sensitizes K-Ras Mutant Pancreatic Cancer Cells to Glutaminase Inhibition
Shin Hamada et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Natural products in drug discovery: advances and opportunities
Atanas G. Atanasov et al.
NATURE REVIEWS DRUG DISCOVERY (2021)
Marine Natural Products: A Potential Source of Anti-hepatocellular Carcinoma Drugs
Xianghai Ren et al.
JOURNAL OF MEDICINAL CHEMISTRY (2021)
The Biological and Clinical Significance of Glutaminase in Luminal Breast Cancer
Brendah K. Masisi et al.
CANCERS (2021)
Inhibition of Metabolism as a Therapeutic Option for Tamoxifen-Resistant Breast Cancer Cells
Friederike Steifensand et al.
CELLS (2021)
CHK1 inhibitor sensitizes resistant colorectal cancer stem cells to nortopsentin
Simone Di Franco et al.
ISCIENCE (2021)
1,2,4-Oxadiazole Topsentin Analogs with Antiproliferative Activity against Pancreatic Cancer Cells, Targeting GSK3β Kinase
Daniela Carbone et al.
CHEMMEDCHEM (2021)
Glutamine synthetase promotes tumor invasion in hepatocellular carcinoma through mediating epithelial-mesenchymal transition
Peng Liu et al.
HEPATOLOGY RESEARCH (2020)
The role of glutaminase in cancer
Brendah K. Masisi et al.
HISTOPATHOLOGY (2020)
Reprogramming of fatty acid metabolism in cancer
Nikos Koundouros et al.
BRITISH JOURNAL OF CANCER (2020)
Targeting Hepatic Glutaminase 1 Ameliorates Non-alcoholic Steatohepatitis by Restoring Very-Low-Density Lipoprotein Triglyceride Assembly
Jorge Simon et al.
CELL METABOLISM (2020)
Targeting Glutamine Addiction in Gliomas
Marta Obara-Michlewska et al.
CANCERS (2020)
Metabolic reprogramming and cancer progression
Brandon Faubert et al.
SCIENCE (2020)
Natural Products as Sources of New Drugs over the Nearly Four Decades from 01/1981 to 09/2019
David J. Newman et al.
JOURNAL OF NATURAL PRODUCTS (2020)
Glutamine reliance in cell metabolism
Hee Chan Yoo et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2020)
Targeting Glutaminolysis: New Perspectives to Understand Cancer Development and Novel Strategies for Potential Target Therapies
Zhefang Wang et al.
FRONTIERS IN ONCOLOGY (2020)
Cancer cell metabolic reprogramming: a keystone for the response to immunotherapy
Michael Cerezo et al.
CELL DEATH & DISEASE (2020)
Discovery of IPN60090, a Clinical Stage Selective Glutaminase-1 (GLS-1) Inhibitor with Excellent Pharmacokinetic and Physicochemical Properties
Michael J. Soth et al.
JOURNAL OF MEDICINAL CHEMISTRY (2020)
Glutaminase-1 (GLS1) inhibition limits metastatic progression in osteosarcoma
L. Ren et al.
CANCER & METABOLISM (2020)
New 1,2,4-Oxadiazole Nortopsentin Derivatives with Cytotoxic Activity
Stella Cascioferro et al.
MARINE DRUGS (2019)
Targeting glutaminase 1 attenuates sternness properties in hepatocellular carcinoma by increasing reactive oxygen species and suppressing Wnt/beta-catenin pathway
Binghua Li et al.
EBIOMEDICINE (2019)
Pyroglutamic acidosis by glutathione regeneration blockage in critical patients with septic shock
Yenifer Gamarra et al.
CRITICAL CARE (2019)
Targeting Glutamine Metabolism for Cancer Treatment
Yeon-Kyung Choi et al.
BIOMOLECULES & THERAPEUTICS (2018)
Characterization of the interactions of potent allosteric inhibitors with glutaminase C, a key enzyme in cancer cell glutamine metabolism
Qingqiu Huang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2018)
Identification of a Potent Tryptophan-Based TRPM8 Antagonist With in Vivo Analgesic Activity
Alessia Bertamino et al.
JOURNAL OF MEDICINAL CHEMISTRY (2018)
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Freddie Bray et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
Polyamine metabolism and cancer: treatments, challenges and opportunities
Robert A. Casero et al.
NATURE REVIEWS CANCER (2018)
Protein interaction evolution from promiscuity to specificity with reduced flexibility in an increasingly complex network
T. Alhindi et al.
SCIENTIFIC REPORTS (2017)
Activation of the NRF2 antioxidant program generates an imbalance in central carbon metabolism in cancer
Volkan I. Sayin et al.
ELIFE (2017)
Glutaminase is essential for the growth of triple-negative breast cancer cells with a deregulated glutamine metabolism pathway and its suppression synergizes with mTOR inhibition
Michael Lampa et al.
PLOS ONE (2017)
Emerging applications of metabolomics in drug discovery and precision medicine
David S. Wishart
NATURE REVIEWS DRUG DISCOVERY (2016)
Dual targeting of glutaminase 1 and thymidylate synthase elicits death synergistically in NSCLC
Jae-Seon Lee et al.
CELL DEATH & DISEASE (2016)
Inhibiting glutaminase in acute myeloid leukemia: metabolic dependency of selected AML subtypes
Polina Matre et al.
ONCOTARGET (2016)
Compensatory glutamine metabolism promotes glioblastoma resistance to mTOR inhibitor treatment
Kazuhiro Tanaka et al.
JOURNAL OF CLINICAL INVESTIGATION (2015)
Structural basis of antizyme-mediated regulation of polyamine homeostasis
Hsiang-Yi Wu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
Myc promotes glutaminolysis in human neuroblastoma through direct activation of glutaminase 2
Daibiao Xiao et al.
ONCOTARGET (2015)
Kidney-type glutaminase (GLS1) is a biomarker for pathologic diagnosis and prognosis of hepatocellular carcinoma
Decai Yu et al.
ONCOTARGET (2015)
Targeting glutamine metabolism sensitizes pancreatic cancer to PARP-driven metabolic catastrophe induced by β-lapachone
Gaurab Chakrabarti et al.
CANCER & METABOLISM (2015)
Glutaminase 2 negatively regulates the PI3K/AKT signaling and shows tumor suppression activity in human hepatocellular carcinoma
Juan Liu et al.
ONCOTARGET (2014)
Computer-Aided Design, Synthesis and Validation of 2-Phenylquinazolinone Fragments as CDK9 Inhibitors with Anti-HIV-1 Tat-Mediated Transcription Activity
Luca Sancineto et al.
CHEMMEDCHEM (2013)
Protein and ligand preparation: parameters, protocols, and influence on virtual screening enrichments
G. Madhavi Sastry et al.
JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN (2013)
Mechanical Stretch Increases MMP-2 Production in Vascular Smooth Muscle Cells via Activation of PDGFR-β/Akt Signaling Pathway
Kyo Won Seo et al.
PLOS ONE (2013)
Polyamines mediate glutamine-dependent induction of the intestinal epithelial heat shock response
Yuji Iwashita et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2011)
Glutaminase 2, a novel p53 target gene regulating energy metabolism and antioxidant function
Wenwei Hu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Proposed minimum reporting standards for chemical analysis
Lloyd W. Sumner et al.
METABOLOMICS (2007)
N-haloalkylation reaction in the presence of trichloroacetic acid
MM Kurbanova
RUSSIAN JOURNAL OF ORGANIC CHEMISTRY (2005)
Share Paper
